Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Niclosamide | 1 | 2020 | 153 | 0.76 | Why? |
| Pregnenediones | 1 | 2020 | 182 | 0.71 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.61 | Why? |
| Serine Endopeptidases | 2 | 2021 | 4606 | 0.36 | Why? |
| Drug Repositioning | 3 | 2021 | 5683 | 0.34 | Why? |
| Antiviral Agents | 9 | 2021 | 41703 | 0.32 | Why? |
| Vero Cells | 7 | 2021 | 14117 | 0.26 | Why? |
| Nucleic Acid Probes | 1 | 2021 | 38 | 0.23 | Why? |
| Phenanthridines | 1 | 2020 | 33 | 0.22 | Why? |
| Amaryllidaceae Alkaloids | 1 | 2020 | 34 | 0.22 | Why? |
| Inhibitory Concentration 50 | 2 | 2021 | 907 | 0.21 | Why? |
| Stephania tetrandra | 1 | 2019 | 9 | 0.21 | Why? |
| Quinazolinones | 1 | 2021 | 135 | 0.20 | Why? |
| Saponins | 1 | 2021 | 171 | 0.20 | Why? |
| Benzylisoquinolines | 1 | 2019 | 64 | 0.19 | Why? |
| Benzamidines | 1 | 2020 | 206 | 0.19 | Why? |
| Complementarity Determining Regions | 1 | 2019 | 147 | 0.19 | Why? |
| Triterpenes | 1 | 2021 | 199 | 0.18 | Why? |
| Organic Anion Transporters, Sodium-Dependent | 1 | 2017 | 26 | 0.18 | Why? |
| Symporters | 1 | 2017 | 80 | 0.17 | Why? |
| Virus Internalization | 3 | 2021 | 7921 | 0.16 | Why? |
| Cell Line | 6 | 2021 | 12040 | 0.16 | Why? |
| Microbial Sensitivity Tests | 2 | 2020 | 2886 | 0.14 | Why? |
| Dose-Response Relationship, Drug | 2 | 2020 | 3776 | 0.13 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.12 | Why? |
| Animals | 9 | 2021 | 78931 | 0.12 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.11 | Why? |
| Sulfonamides | 1 | 2020 | 1294 | 0.11 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.11 | Why? |
| Coronavirus OC43, Human | 1 | 2019 | 1157 | 0.11 | Why? |
| South Africa | 1 | 2021 | 3326 | 0.11 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.11 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.11 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.10 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2021 | 8843 | 0.10 | Why? |
| Drug Design | 1 | 2021 | 2627 | 0.09 | Why? |
| Plant Extracts | 1 | 2019 | 1514 | 0.09 | Why? |
| Drug Discovery | 1 | 2020 | 3092 | 0.08 | Why? |
| Structure-Activity Relationship | 2 | 2021 | 2219 | 0.07 | Why? |
| Rats | 2 | 2021 | 2764 | 0.06 | Why? |
| Platycodon | 1 | 2021 | 15 | 0.06 | Why? |
| Microsomes | 1 | 2021 | 26 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| Gene Dosage | 1 | 2021 | 101 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Receptors, Virus | 1 | 2017 | 5659 | 0.05 | Why? |
| Half-Life | 1 | 2021 | 298 | 0.05 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2021 | 144 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Hydrogen Bonding | 1 | 2020 | 599 | 0.05 | Why? |
| Drug Synergism | 1 | 2021 | 833 | 0.04 | Why? |
| Lysosomes | 1 | 2021 | 416 | 0.04 | Why? |
| Cricetulus | 1 | 2020 | 936 | 0.04 | Why? |
| Humans | 12 | 2021 | 930598 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Molecular Structure | 1 | 2020 | 1539 | 0.04 | Why? |
| Cell Survival | 1 | 2021 | 1581 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2021 | 253789 | 0.04 | Why? |
| User-Computer Interface | 1 | 2021 | 1068 | 0.03 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.03 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2019 | 1647 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Dogs | 1 | 2020 | 2529 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Mice | 2 | 2021 | 21357 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Carcinoma, Hepatocellular | 1 | 2017 | 1222 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.02 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2020 | 6902 | 0.02 | Why? |
| Republic of Korea | 1 | 2017 | 5858 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
| Middle Aged | 1 | 2017 | 270681 | 0.00 | Why? |
| Male | 1 | 2017 | 367725 | 0.00 | Why? |
| Female | 1 | 2017 | 380317 | 0.00 | Why? |
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(89)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_